Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.39 USD 6.5% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
Neogenomics Inc

Current Assets 590.2m
Cash & Short-Term Investments 387.8m
Receivables 151.4m
Other Current Assets 51m
Non-Current Assets 1.1B
PP&E 174.5m
Intangibles 870.8m
Other Non-Current Assets 5.6m
Current Liabilities 296.4m
Accounts Payable 16.5m
Accrued Liabilities 78.9m
Other Current Liabilities 201m
Non-Current Liabilities 436.5m
Long-Term Debt 340m
Other Non-Current Liabilities 96.5m

Balance Sheet
Neogenomics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
34
23
13
13
10
173
229
317
263
342
Cash Equivalents
34
23
13
13
10
173
229
317
263
342
Short-Term Investments
0
0
0
0
0
0
68
199
175
73
Total Receivables
21
49
56
60
77
94
109
114
122
131
Accounts Receivables
21
49
56
60
77
94
109
114
122
131
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
3
5
6
8
9
14
30
23
24
24
Other Current Assets
2
5
5
5
8
9
14
29
21
26
Total Current Assets
59
82
79
86
104
291
449
682
605
597
PP&E Net
15
35
34
37
61
91
132
212
199
184
PP&E Gross
15
35
34
37
61
91
132
212
199
184
Accumulated Depreciation
20
27
27
41
50
69
93
110
132
158
Intangible Assets
4
88
77
74
140
127
121
442
408
373
Goodwill
3
146
147
147
198
199
211
527
523
523
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
0
30
0
0
0
Other Long-Term Assets
0
0
0
1
3
3
46
7
5
5
Other Assets
3
146
147
147
198
199
211
527
523
523
Total Assets
81
N/A
351
+333%
337
-4%
345
+2%
505
+47%
710
+40%
988
+39%
1 870
+89%
1 740
-7%
1 681
-3%
Liabilities
Accounts Payable
6
13
17
11
18
20
25
18
21
20
Accrued Liabilities
5
14
13
16
28
32
41
63
62
74
Short-Term Debt
0
9
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
5
9
9
14
10
3
1
0
0
Other Current Liabilities
0
0
0
1
1
2
4
5
8
2
Total Current Liabilities
15
40
38
37
61
64
73
87
90
96
Long-Term Debt
5
57
97
96
98
95
169
533
535
538
Deferred Income Tax
1
16
15
7
23
16
5
56
35
24
Other Liabilities
0
0
0
0
3
28
46
86
82
81
Total Liabilities
21
N/A
113
+447%
151
+33%
140
-7%
185
+32%
202
+9%
294
+45%
762
+159%
742
-3%
740
0%
Equity
Common Stock
0
29
23
33
0
0
0
0
0
0
Retained Earnings
19
22
53
58
51
11
7
15
159
247
Additional Paid In Capital
80
232
216
230
372
520
701
1 124
1 161
1 190
Other Equity
0
0
0
0
1
2
0
1
4
2
Total Equity
60
N/A
238
+294%
187
-22%
205
+10%
320
+57%
507
+58%
694
+37%
1 108
+60%
998
-10%
942
-6%
Total Liabilities & Equity
81
N/A
351
+333%
337
-4%
345
+2%
505
+47%
710
+40%
988
+39%
1 870
+89%
1 740
-7%
1 681
-3%
Shares Outstanding
Common Shares Outstanding
60
76
79
81
95
105
112
124
127
127
Preferred Shares Outstanding
0
0
7
7
0
0
0
0
0
0

See Also

Discover More